Inventor
Tinghu Zhang
Inventor
Brookline, MA, US
Overview
Patents· 17 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
C07DHeterocyclic compounds30%
A61KPreparations for medical, dental or toiletry purposes25%
Y02ATechnologies for adaptation to climate change5%
G01NInvestigating or analysing materials by determining their chemical or physical properties4%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium2%
C07KPeptides2%
C12NMicroorganisms or enzymes2%
C12YEnzymes2%
PatentTitleYear
11,040,957Heteroaromatic compounds useful for the treatment of proliferative diseases202110,875,844Salicylate inhibitors of MELK and methods of use202010,870,651Inhibitors of cyclin-dependent kinase 7 (CDK7)202010,865,205Degradation of cyclin-dependent kinase 8 (CDK8) by conjugation of CDK8 inhibitors with E3 ligase ligand and methods of use202010,865,204Degradation of cyclin-dependent kinase 4/6 (CDK4/6) by conjugation of CDK4/6 inhibitors with E3 ligase ligand and methods of use202010,787,436Inhibitors of cyclin-dependent kinase 7 (CDK7)202010,781,207Inhibitors of mutant isocitrate dehydrogenases and compositions and methods thereof202010,695,3464,6-pyrimidinylene derivatives and uses thereof202010,550,121Inhibitors of cyclin-dependent kinases202010,544,138Tricyclic kinase inhibitors of MELK and methods of use202010,532,103Degradation of cyclin-dependent kinase 9 (CDK9) by conjugation of CDK9 inhibitors with E3 ligase ligand and methods of use202010,508,082Substituted 6,11-dihydro-5H-benzo[b]carbazoles as inhibitors of ALK and SRPK201910,342,798Fused bicyclic pyrimidine derivatives and uses thereof201910,144,730Inhibitors of c-Jun-201810,112,927Inhibitors of cyclin-dependent kinase 7 (CDK7)201810,047,070Polycyclic inhibitors of cyclin-dependent kinase 7 (CDK7)20189,382,239'Inhibitors of c-Jun-N-terminal kinase (JNK)'2016Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2016–2021Patents assigned to DANA FARBER CANCER INST INC (16)· patent assignee history
2016–2021Based in Brookline, MA, US· patent location history
2020Patents assigned to ISOCURE BIOSCIENCES INC (1)· patent assignee history
2021Patents assigned to SYROS PHARMACEUTICALS INC (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| DANA FARBER CANCER INST INC | 16 | 2016–2021 |
| ISOCURE BIOSCIENCES INC | 1 | 2020 |
| SYROS PHARMACEUTICALS INC | 1 | 2021 |
Locations
| Location | Patents | Span |
|---|---|---|
| Brookline, Massachusetts, US | 17 | 2016–2021 |